Optain is working to make retinal screening simple, accessible, and standard in frontline care. Diabetic retinopathy is a leading cause of blindness, yet preventable and treatable with routine screening. The barrier has never been the science - it's fit. Screening tools built for specialists were never designed to fit the reality of primary care. Optain provides a complete end-to-end solution - from image capture to AI/teleophthalmology-based grading* and reporting, designed to fit within a scheduled primary care visit, driving measurable clinical impact and ROI. Optain was founded in 2023, building on more than a decade of Australian AI-ophthalmology research led by Professor Mingguang He, and operates across frontline care globally. *AI-based grading: not currently available in the US and certain markets. Teleophthalmology: currently US only. Contact us for details.
| Employees | 29 (15 on RocketReach) |
| Founded | 2023 |
| Industry | Hospitals and Health Care |
Looking for a particular Optain employee's phone or email?
Optain Questions
Jeff Dunkel is the CEO of Optain.
15 people are employed at Optain.
Top Optain Employees
-
Jeff Dunkel
Chief Executive Officer at Optain
Matthews, NC, US15+ -
Zachary Tan
President, Co-Founder at Optain
New York, NY, US25 -
24
-
Rainer Grote
Senior Vice President at Optain
Melbourne, VIC, AU15 -
Alejandra MacIel
Director of Clinical Operations at Optain
San Diego, CA, US23 -
45+
-
Sue Dafnias
Director - Marketing and Adoption at Optain
Melbourne, VIC, AU1 -
Wei
Chief Technology Officer at Optain
Melbourne, VIC, AU3 -
11
Related Companies
